Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,935 total articles
Sezzle has moved from a pure BNPL player to a broader fintech play with product expansion, strong subscriber growth and healthy cash generation. At roughly $5.17B market cap and trading near $153.63, the stock looks like a high-growth compounder that can re-rate if execution on new products and continued revenue acceleration hold. This trade target…
Oscar Health looks to be transitioning from growth-at-all-costs to profitable scale. Membership gains and margin leverage have pushed free cash flow positive and management now guides to operating income in 2026. At roughly $8.5B market cap and $4.34B enterprise value, the stock offers a tactical long with defined entry, stop and target levels cali…
Alphabet reported powerful Q2 growth in Search and Google Cloud and followed with heavy capex guidance. The market punished the stock on the capex news, but fundamentals point to continued AI-led revenue and margin expansion. This trade idea lays out an actionable long trade with entry, stop and target for a long-term (180 trading days) horizon and…
Astec Industries is delivering above-peer growth in its Materials segment and guiding to materially higher adjusted EBITDA for 2026. The market has not fully priced that improvement: while the trailing P/E sits elevated, the company's $1.61B enterprise value implies an attractive ~9x EV/EBITDA on management's 2026 midpoint. We lay out an actionable…
Nu Holdings is the dominant digital challenger bank in Latin America, growing customers rapidly while maintaining strong returns on equity and improving operating efficiency. The stock trades around $14 with a market cap near $71B and a trailing P/E near 21x — an attractive entry for investors who believe growth and margin expansion will continue. …
Alphabet is delivering outsized AI-driven growth in Search and Cloud while guiding materially higher capex. The market punished shares on headline spending, but fundamentals - 17% Search growth, 82% Google Cloud growth, $64.4B free cash flow and a $514B backlog - argue for buying the dip. This trade idea outlines a long-term (180 trading days) plan…
Exelixis is a liquid, profitable oncology company trading near $55.40 with a $13.9B market cap. Recent pipeline progress for zanzalintinib and durable cash flow from Cabometyx create a compelling mid-term long trade: entry at $55.50, stop at $50.00, target $64.00 over ~45 trading days. The balance sheet and free cash flow ($912M) underpin execution…
Alibaba is trading well below its 52-week high despite improving technical momentum and a clear pathway to monetize large-language-model assets through Alibaba Cloud and product integrations. This trade idea takes a constructive view on Qwen-driven AI adoption while defining risk with a tight stop and a realistic mid-term target.
TXO Partners (TXO) offers a favorable risk-reward into Q2 earnings: strong free cash flow, an attractive distribution ($0.36 quarterly), reasonable leverage, and constructive technicals. Enter around $13.10 with a $12.20 stop and a primary target at $15.50 (52-week high) over a mid-term (45 trading days) horizon.
Seagate ($STX) still benefits from AI-driven data-center storage demand, but the stock carries a premium — P/E roughly 71x and P/FCF ~85x — that leaves the market little tolerance for disappointing guidance. This trade idea outlines an actionable long entry on weakness ahead of earnings with a defined stop and target across a 180 trading-day horizo…
Himax Technologies has pulled roughly half off its June highs. Fundamentals show product traction in OLED touch ICs, LCoS microdisplays for AR, and growing edge-AI capabilities, while the valuation and technicals suggest a tactical long-swing opportunity. This trade targets a recovery toward the mid-$teens as mean reversion meets upcoming catalysts…
Capital One's Q2 performance confirms improving credit trends and a profitable capital base while the Discover migration (starting 07/27/2026) and targeted $2.7B of synergies support a re-rating. The stock trades at roughly mid-40s P/E and near book value, leaving upside if delivery on integration and continued credit discipline persist. Trade idea…
A favorable regulatory development on therapeutic peptides, paired with management's operational adjustments and resilient revenue guidance, justify upgrading Hims & Hers to a Buy. Short interest and convertible debt remain tangible risks, but the setup offers asymmetric upside for disciplined, sized positions over the next 180 trading days.
Tarsus has turned a clear commercial engine with XDEMVY, delivering $451.4M in 2025 net product sales and a strongly profitable gross margin profile. Q1 2026 net product sales topped $145M (up ~85% YoY) and management reaffirmed full-year guidance of $670-700M. With a market cap of roughly $2.5B and $709M of cash on the balance sheet, the equity lo…
Charter Communications is trading at multi-year distressed multiples despite positive free cash flow, low P/E and attractive EV/EBITDA. This is a tactical long trade: enter $119.19, stop $98.00, target $170.00 with a long-term (180 trading days) horizon. The risk/reward favors buyers who accept industry headwinds and near-term headline volatility.
Micron looks attractively positioned after the pullback. Strong AI/data-center demand, impressive profitability metrics, and a conservative balance sheet make a long entry compelling. Trade plan anchored to product-led revenue upside from the Kimi K3 ramp, with clear stops and a 180-trading-day horizon.
Ladder Capital (LADR) trades under $10 with a near 9% yield and improving dividend coverage supported by roughly $100M in free cash flow. This trade idea buys the rebound toward prior resistance while protecting against downside through a tight stop. The thesis rests on steady distributable earnings, sub-1.0 price-to-book and a market cap of about …
SpaceX's optionality from Starlink recurring revenue, Starship scale economics, and a predictable government revenue base is being discounted. I upgrade to a buy and lay out an actionable entry, target and stop for a long trade that expects re-rating over the next 180 trading days.
Otis is a high-quality, service-heavy industrial franchise showing steady cash generation and a shareholder-friendly dividend. Near-term technicals and industry headwinds constrain immediate upside, but the company's scale in service and steady free cash flow support a constructive mid-term trade and a longer-term bullish view.
Visa looks set to deliver another reliable quarter driven by resilient payments volumes, cross-border recovery and robust cash generation. Valuation is full but not extreme for a dominant, high-margin franchise. This trade idea lays out a short-term (10 trading days) long with an entry at $354.00, stop at $344.00 and a $370 target.
Dave Inc. has become a profitable, high-margin fintech but its valuation and recent technical setup leave it exposed to a downside re-rating. For investors who want banking exposure without payday-like credit economics, owning coastal, BaaS-style franchises is the cleaner trade. We lay out an actionable short on DAVE with entry, stop and target, pl…
Brookfield Infrastructure (BIP) is a high-quality infrastructure owner with inflation-linked cash flows and a healthy distribution. The company announced a plan to simplify into a single public corporation, and that corporate action plus upcoming Q2 results create a clear catalyst window. This trade idea outlines a long entry with precise entry, st…
AbbVie offers a durable dividend backed by strong free cash flow and a diversified drug portfolio. At $258.38 the stock trades like a mature pharma with growth optionality from immunology and oncology assets. This trade idea lays out an entry at $258.38, stop at $235.00 and a 180-day target of $300.00, with concrete catalysts and downside scenarios…
RTX is trading up on a clear beat-and-raise storyline: robust backlog, defensive tailwinds from rising defense budgets, and healthy free cash flow. Valuation is rich but not irrational given scale and cash generation. This trade targets a mid-term upside while protecting capital with a defined stop.
Stride has stabilized execution after last year’s platform troubles, reinforced guidance and lifted adjusted op income expectations, and today trades at roughly $3.66B market cap and single-digit EV/EBITDA multiples. This trade idea lays out an actionable long with entry, stop and target and explains why a revisit to prior multiples makes a 50%+ up…
